Literature DB >> 7563086

The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.

T J Daly1, R C Doten, J R Rusche, M Auer.   

Abstract

The ability of HIV-1 Rev to successfully discriminate between specific Rev-responsive elements (RRE) and nonspecific binding sites in the presence of excess nonspecific RNA was examined using filter binding, gel shift, and gel filtration techniques, using purified M4 Rev mutant protein and endoproteinase Lys-C cleaved wild-type Rev. The M4 Rev displayed a slightly reduced binding affinity to the RRE, as well as a tenfold decrease in its ability to discriminate the RRE from non-specific RNA compared to the wild-type Rev. Gel shift and gel filtration chromotography data also showed decreased ability of the mutant to multimerize in the absence or presence of the RRE. The Lys-C cleaved Rev, which lacks the amino-terminal 20 amino acids of the protein, displayed less ability to discriminate the RRE from nonspecific RNA compared to either the wild-type or the M4 mutant Rev and appeared unable to form protein-protein interactions, yet still bound sense and antisense RNA species with high affinity (Kd was in the nanomolar concentration range). A 40 amino acid peptide containing the arginine-rich RRE binding domain of Rev was also observed to interact with both the RRE and antisense RNA fragments with a binding constant of about 1 x 10(-9) M. However, the peptide displayed almost no ability to discriminate between the RRE and a comparably sized antisense RRE. The loss in ability to discriminate correct from incorrect binding sites correlates with overall decreases in the alpha-helical character of the protein and perturbations within the amino terminus. The amino terminus of Rev is likely to maintain the conformational integrity of the arginine rich RRE binding domain which is required for specific RNA binding site discrimination or stabilization of specific Rev-RRE interactions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7563086     DOI: 10.1006/jmbi.1995.0549

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  9 in total

1.  Toward antiviral strategies that resist viral escape.

Authors:  D Endy; J Yin
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

2.  Identification of a domain in human immunodeficiency virus type 1 rev that is required for functional activity and modulates association with subnuclear compartments containing splicing factor SC35.

Authors:  D M D'Agostino; T Ferro; L Zotti; F Meggio; L A Pinna; L Chieco-Bianchi; V Ciminale
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Stereospecificity of short Rev-derived peptide interactions with RRE IIB RNA.

Authors:  Alexander Litovchick; Robert R Rando
Journal:  RNA       Date:  2003-08       Impact factor: 4.942

4.  High-affinity and specific recognition of human thyroid stimulating hormone (hTSH) by in vitro-selected 2'-amino-modified RNA.

Authors:  Y Lin; D Nieuwlandt; A Magallanez; B Feistner; S D Jayasena
Journal:  Nucleic Acids Res       Date:  1996-09-01       Impact factor: 16.971

5.  Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.

Authors:  Y S Nam; A Petrovic; K S Jeong; S Venkatesan
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Functional analysis of the human immunodeficiency virus type 1 Rev protein oligomerization interface.

Authors:  S L Thomas; M Oft; H Jaksche; G Casari; P Heger; M Dobrovnik; D Bevec; J Hauber
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Rapid and efficient purification of RNA-binding proteins: application to HIV-1 Rev.

Authors:  Marco Marenchino; David W Armbruster; Mirko Hennig
Journal:  Protein Expr Purif       Date:  2008-09-25       Impact factor: 1.650

8.  Limited nucleotide changes in the Rev response element (RRE) during HIV-1 infection alter overall Rev-RRE activity and Rev multimerization.

Authors:  Emily A Sloan; Mary F Kearney; Laurie R Gray; Kathryn Anastos; Eric S Daar; Joseph Margolick; Frank Maldarelli; Marie-Louise Hammarskjold; David Rekosh
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

9.  Highly precise measurement of HIV DNA by droplet digital PCR.

Authors:  Matthew C Strain; Steven M Lada; Tiffany Luong; Steffney E Rought; Sara Gianella; Valeri H Terry; Celsa A Spina; Christopher H Woelk; Douglas D Richman
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.